Table 3.
Major adverse cardiovascular events by left ventricular ejection fraction group.
| NLVEF | HDLVEF | RLVEF | p-Value | |
|---|---|---|---|---|
| n | 309 | 47 | 63 | |
| Total MACE (%) | 119 (38.5) | 24 (51.1) | 42 (66.7) | <0.001 |
| Myocardial injury (%) | 18 (5.8) | 3 (6.4) | 13 (20.6) | <0.001 |
| Stroke (%) | 2 (0.6) | 0 (0.0) | 0 (0.0) | 0.699 |
| Life-threatening arrhythmia (%) | 38 (12.3) | 10 (21.3) | 10 (15.9) | 0.222 |
| DVT (%) | 17 (5.5) | 7 (14.9) | 7 (11.1) | 0.034 |
| HF exacerbation (%) | 10 (3.2) | 1 (2.1) | 21 (33.3) | <0.001 |
| Requiring RRT (%) | 41 (13.3) | 15 (31.9) | 14 (22.2) | 0.003 |
| PE (%) | 26 (8.4) | 6 (12.8) | 2 (3.2) | 0.177 |
NLVEF = normal left ventricular ejection fraction; HDLVEF = hyperdynamic left ventricular ejection fraction; RLVEF = reduced left ventricular ejection fraction; ICU = intensive care unit; MACE = major adverse cardiac events; DVT = deep vein thrombosis; HF = heart failure; RRT = renal replacement therapy; PE = pulmonary embolism.